Results 231 to 240 of about 125,484 (349)

Cost-effectiveness of proton-pump inhibitors for maintenance therapy of erosive reflux esophagitis [PDF]

, 2001
Bonnie B. Dean, Reshmi Siddique, Beverly D. Yamashita, Ashoke Bhattacharjya, Joshua J. Ofman   +4 more
openalex   +1 more source

Nanostructured drug delivery systems for posterior segment eye diseases: Strategies to defy ocular barriers

BMEMat, EarlyView.
Efficient drug delivery to the posterior segment of the eye has long been a challenging issue due to the complex ocular barriers. The review focuses on the promise held by nanoplatforms for barrier penetration and the key mechanisms involved, also highlighting their advantages in achieving efficient drug delivery and superior treatment of PSEDs ...
Yifan Shen, Ying Yao, Yan Zhang, Xinyu Shi, Ling Bai, Yang Zhong, Yan Zhang, Kun Zhang   +7 more
wiley   +1 more source

Proton pump inhibitors reduce survival outcomes in patients treated with capecitabine: meta-analysis. [PDF]

Ecancermedicalscience
Mohyeldeen D, Arafat W.
europepmc   +1 more source

Proton pump inhibitors: a study of GPs' prescribing

, 2001
Miren I Jones, Sheila Greenfield, Sue Jowett, Colin Bradley, Ruth L. Seal   +4 more
openalex   +1 more source

Proton pump inhibitors and gastric acid secretion [PDF]

, 2001
M. Michael Wolfe, Lynda S. Welage, George Sachs   +2 more
openalex   +1 more source

Single‐component cationic polyethylenimine thermogel for sustained and localized gene delivery to combat multi‐drug resistant cancer

BMEMat, EarlyView.
A cationic thermogelling copolymer employing branched PEI‐25 kDa as the sole hydrophilic segment can be facilely complexed with plasmid by physical mixing in the sol phase. Spontaneous gelation is achieved via self‐assembly after injection due to physiological temperature. Sustained and localized release of plasmid from the cationic PEI‐thermogel leads
Qianyu Lin, Minting Liu, Lingjie Ke, Nicholas Wei Xun Ong, Joey Hui Min Wong, Cally Owh, Valerie Ow, Belynn Sim, Yi Jian Boo, Jason Y. C. Lim, Yunlong Wu, Xian Jun Loh   +11 more
wiley   +1 more source

Concomitant use of clopidogrel and proton pump inhibitors: A retrospective analysis of prescription behaviour. [PDF]

Br J Clin Pharmacol
Wilkes S, van de Wiel K, Mulder K, van Ballegooijen H, Zaal R, van der Kuy H.   +5 more
europepmc   +1 more source

COX-2 inhibitor compared with proton pump inhibitor in the prevention of recurrent ulcer complications in high-risk patients taking NSAIDs

, 2001
Kam‐Chuen Lai, Kent‐Man Chu, Wai‐Mo Hui, Chun-Yu Wong, Wayne Hc Hu, Wai-Man Yuen, Man‐Fung Yuen, On-On Chan, Ching‐Lung Lai, Ka-Kit Lau, Chi-Kuen Chan, Shiu‐Kum Lam   +11 more
openalex   +1 more source

South African Propolis: Anti‐Helicobacter pylori Activity, Chemistry, and Toxicity

Chemistry &Biodiversity, EarlyView.
ABSTRACT Propolis, a resin‐like substance produced by bees, has previously shown antimicrobial activity against the ulcer‐causing gut pathogen Helicobacter pylori. South African propolis, however, was yet to be investigated. This study aimed to investigate a comprehensive range of South African propolis for its antimicrobial activity against H.
Sarhana Dinat, Ané Orchard, Efficient Ncube, Weiyang Chen, Alvaro Viljoen, Sandy van Vuuren   +5 more
wiley   +1 more source

Inappropriate Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis in a Tertiary Care Hospital: A Cross-Sectional Study. [PDF]

Cureus
Alam S, Qureshi SI, Shakeel A, Javed A, Sami N, Ahmad B.   +5 more
europepmc   +1 more source